Veradigm Inc. (NASDAQ:MDRX – Get Free Report) shares fell 6.6% during trading on Wednesday . The company traded as low as $8.71 and last traded at $8.71. 672 shares changed hands during mid-day trading, a decline of 100% from the average session volume of 1,768,863 shares. The stock had previously closed at $9.33.
Wall Street Analyst Weigh In
Separately, StockNews.com assumed coverage on Veradigm in a research report on Tuesday. They set a “hold” rating for the company. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Veradigm has a consensus rating of “Hold” and an average target price of $12.00.
Read Our Latest Report on Veradigm
Veradigm Stock Up 0.5 %
Hedge Funds Weigh In On Veradigm
A number of institutional investors and hedge funds have recently made changes to their positions in MDRX. Wellington Management Group LLP grew its stake in shares of Veradigm by 117.8% in the 4th quarter. Wellington Management Group LLP now owns 5,806,297 shares of the software maker’s stock worth $60,908,000 after buying an additional 3,140,483 shares in the last quarter. Tyro Capital Management LLC purchased a new position in shares of Veradigm during the 1st quarter worth about $9,055,000. Goldman Sachs Group Inc. boosted its stake in shares of Veradigm by 6.6% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,596,684 shares of the software maker’s stock worth $16,749,000 after purchasing an additional 99,528 shares during the period. Vanguard Group Inc. boosted its stake in shares of Veradigm by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock worth $149,754,000 after purchasing an additional 95,291 shares during the period. Finally, Forest Hill Capital LLC purchased a new position in shares of Veradigm during the 4th quarter worth about $210,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
- Five stocks we like better than Veradigm
- Energy and Oil Stocks Explained
- 3 Momentum Trades for October With Ample Upside Ahead
- Why is the Ex-Dividend Date Significant to Investors?
- Roblox Dips on Short Report—Here’s Why It Could Bounce Back Fast
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 2 Reasons to Jump on Apple Stock Now and 1 Reason to Think Twice
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.